News
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
2h
Investor's Business Daily on MSNDow Jones Hits Record High On Dovish Powell After AI Worries, Walmart Woes: Weekly Review
The Dow Jones and S&P 500 jumped Friday to record highs on Fed chief Jerome Powell's dovish Jackson Hole speech.
16h
MyChesCo on MSNMadrigal Pharmaceuticals Secures EU Approval for First-Ever MASH Therapy
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced that the European Commission (EC) has granted conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results